Provectus Biopharmaceuticals - 45 Year Dividend History | PVCT

Historical dividend payout and yield for Provectus Biopharmaceuticals (PVCT) since 1971. The current TTM dividend payout for Provectus Biopharmaceuticals (PVCT) as of October 13, 2016 is $0.00. The current dividend yield for Provectus Biopharmaceuticals as of October 13, 2016 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.079B $0.001B
Provectus Biopharmaceuticals specializes in developing oncology and dermatology therapies. The company's product portfolio consists of PV-10 Melanoma, PH-10 Psoriasis, PH-10 Atopic Dermatitis, PV-10 Breast Cancer, PV-10 Liver Metastasis and PV-10 Mechanism of Action which are in clinical trials. Provectus Biopharmaceuticals Inc., formerly known as Provectus Pharmaceuticals, Inc., is based in Knoxville, Tennessee.
Stock Name Country Market Cap PE Ratio